Total Payments
$6,066
2024 Payments
$1,403
Companies
45
Transactions
149
Medicare Patients
275
Medicare Billing
$37,689
Payment Breakdown by Category
Food & Beverage$4,199 (69.2%)
Consulting$1,260 (20.8%)
Education$585.72 (9.7%)
Travel$22.08 (0.4%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,199 | 141 | 69.2% |
| Consulting Fee | $1,260 | 1 | 20.8% |
| Education | $585.72 | 6 | 9.7% |
| Travel and Lodging | $22.08 | 1 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Biotech, Inc. | $1,346 | 5 | $0 (2024) |
| Merck Sharp & Dohme LLC | $418.28 | 9 | $0 (2024) |
| Lilly USA, LLC | $412.50 | 8 | $0 (2024) |
| Amgen Inc. | $344.52 | 7 | $0 (2022) |
| Celgene Corporation | $279.86 | 12 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $278.74 | 11 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $237.68 | 5 | $0 (2024) |
| Daiichi Sankyo Inc. | $218.94 | 6 | $0 (2024) |
| Alexion Pharmaceuticals, Inc. | $160.50 | 3 | $0 (2024) |
| PFIZER INC. | $160.37 | 8 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,403 | 51 | Novartis Pharmaceuticals Corporation ($143.88) |
| 2023 | $2,317 | 41 | Janssen Biotech, Inc. ($1,324) |
| 2022 | $733.09 | 32 | Celgene Corporation ($74.55) |
| 2021 | $124.19 | 1 | Novo Nordisk Inc ($124.19) |
| 2019 | $194.96 | 4 | Servier Pharmaceuticals LLC ($121.90) |
| 2018 | $651.27 | 12 | Lilly USA, LLC ($136.36) |
| 2017 | $642.50 | 8 | Merck Sharp & Dohme Corporation ($244.05) |
All Payment Transactions
149 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/03/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), LYNPARZA | Food and Beverage | In-kind items and services | $21.88 | General |
| Category: ONCOLOGY | ||||||
| 11/13/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $26.59 | General |
| 10/28/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $20.66 | General |
| Category: ONCOLOGY | ||||||
| 10/03/2024 | Celgene Corporation | REBLOZYL (Biological) | Food and Beverage | Cash or cash equivalent | $27.87 | General |
| Category: Hematology | ||||||
| 09/19/2024 | GlaxoSmithKline, LLC. | OJJAARA (Drug) | Food and Beverage | In-kind items and services | $21.94 | General |
| Category: ONCOLOGY | ||||||
| 08/01/2024 | Celgene Corporation | REBLOZYL (Biological) | Food and Beverage | Cash or cash equivalent | $30.31 | General |
| Category: Hematology | ||||||
| 07/29/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $28.66 | General |
| 07/25/2024 | BeiGene USA, Inc. | BRUKINSA (Drug) | Food and Beverage | In-kind items and services | $23.95 | General |
| Category: Oncology | ||||||
| 07/25/2024 | PFIZER INC. | INLYTA (Drug), XTANDI, TALZENNA | Food and Beverage | In-kind items and services | $21.58 | General |
| Category: ONCOLOGY | ||||||
| 07/22/2024 | SOBI, INC | DOPTELET (Drug) | Food and Beverage | In-kind items and services | $25.92 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 07/16/2024 | PUMA BIOTECHNOLOGY, INC. | — | Food and Beverage | In-kind items and services | $28.09 | General |
| 07/11/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $31.99 | General |
| Category: Oncology | ||||||
| 07/09/2024 | Novartis Pharmaceuticals Corporation | SCEMBLIX (Drug) | Food and Beverage | In-kind items and services | $20.49 | General |
| Category: Oncology | ||||||
| 07/09/2024 | Novartis Pharmaceuticals Corporation | SCEMBLIX (Drug) | Food and Beverage | In-kind items and services | $1.11 | General |
| Category: Oncology | ||||||
| 07/08/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $11.69 | General |
| Category: ONCOLOGY | ||||||
| 06/26/2024 | E.R. Squibb & Sons, L.L.C. | OPDUALAG (Drug) | Food and Beverage | Cash or cash equivalent | $20.28 | General |
| Category: Oncology | ||||||
| 06/25/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Education | In-kind items and services | $98.99 | General |
| Category: ONCOLOGY | ||||||
| 06/25/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $22.55 | General |
| Category: ONCOLOGY | ||||||
| 06/18/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $21.35 | General |
| Category: ONCOLOGY | ||||||
| 05/23/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $28.53 | General |
| Category: ONCOLOGY | ||||||
| 05/21/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $25.04 | General |
| 05/16/2024 | Karyopharm Therapeutics Inc. | XPOVIO (Drug) | Food and Beverage | In-kind items and services | $26.08 | General |
| Category: Oncology | ||||||
| 05/14/2024 | Celgene Corporation | REBLOZYL (Biological) | Food and Beverage | Cash or cash equivalent | $14.77 | General |
| Category: Hematology | ||||||
| 05/13/2024 | Stemline Therapeutics Inc. | Orserdu (Drug) | Food and Beverage | In-kind items and services | $27.34 | General |
| Category: Oncology | ||||||
| 05/13/2024 | BeiGene USA, Inc. | BRUKINSA (Drug) | Food and Beverage | In-kind items and services | $21.23 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 89 | 157 | $19,860 | $7,730 |
| 2021 | 1 | 23 | 35 | $14,000 | $2,782 |
| 2020 | 6 | 163 | 288 | $122,210 | $27,177 |
Total Patients
275
Total Services
480
Medicare Billing
$37,689
Procedure Codes
11
All Medicare Procedures & Services
11 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 35 | 54 | $15,058 | $5,758 | 38.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 12 | 13 | $2,597 | $1,031 | 39.7% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 12 | 44 | $1,417 | $555.28 | 39.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 30 | 46 | $788.44 | $386.40 | 49.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 23 | 35 | $14,000 | $2,782 | 19.9% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 12 | 72 | $38,520 | $7,002 | 18.2% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 39 | 39 | $29,250 | $5,340 | 18.3% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 41 | 73 | $29,200 | $5,334 | 18.3% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 38 | 70 | $11,900 | $4,431 | 37.2% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 22 | 22 | $10,340 | $3,905 | 37.8% |
| 99358 | Prolonged patient service without direct patient contact first hour | Office | 2020 | 11 | 12 | $3,000 | $1,166 | 38.9% |
About Dr. Esha Sachdev, MD
Dr. Esha Sachdev, MD is a Internal Medicine healthcare provider based in Long Beach, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/04/2013. The National Provider Identifier (NPI) number assigned to this provider is 1114260460.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Esha Sachdev, MD has received a total of $6,066 in payments from pharmaceutical and medical device companies, with $1,403 received in 2024. These payments were reported across 149 transactions from 45 companies. The most common payment nature is "Food and Beverage" ($4,199).
As a Medicare-enrolled provider, Sachdev has provided services to 275 Medicare beneficiaries, totaling 480 services with total Medicare billing of $37,689. Data is available for 3 years (2020–2023), covering 11 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Hematology & Oncology
- Location Long Beach, CA
- Active Since 04/04/2013
- Last Updated 09/23/2024
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1114260460
Products in Payments
- RYBREVANT (Drug) $1,300
- KEYTRUDA (Biological) $418.28
- KISQALI (Drug) $212.22
- Enhertu (Drug) $169.06
- CYRAMZA (Drug) $168.56
- ULTOMIRIS (Biological) $160.50
- Cabometyx (Drug) $131.40
- Lenvima (Drug) $128.45
- Alecensa (Biological) $128.43
- Wegovy (Drug) $124.19
- BRUKINSA (Drug) $123.40
- Kyprolis (Biological) $123.13
- REBLOZYL (Biological) $122.23
- NINLARO (Drug) $121.98
- ONCASPAR (Drug) $121.90
- VENCLEXTA (Drug) $113.31
- INLYTA (Drug) $89.36
- Pomalyst (Drug) $84.81
- XPOVIO (Drug) $68.39
- OPDIVO (Biological) $62.85
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Long Beach
Jennifer Connelly, D.o, D.O
Internal Medicine — Payments: $275,877
Internal Medicine $275,877
Dr. Mark Lee, Md, MD
Internal Medicine — Payments: $142,649
Internal Medicine $142,649
Dr. Mark Leibowitz, M.d, M.D
Internal Medicine — Payments: $103,211
Internal Medicine $103,211
Dr. Steven Appleby, Md, MD
Internal Medicine — Payments: $101,644
Internal Medicine $101,644
Dr. Milan Sheth, Md, MD
Internal Medicine — Payments: $71,682
Internal Medicine $71,682
Katya Corado, M.d, M.D
Internal Medicine — Payments: $30,357
Internal Medicine $30,357